HOME >> BIOLOGY >> NEWS
High rates of HIV infection documented among young Nepalese girls sex-trafficked to India

ho had been sex-trafficked from Nepal to India between the years 1997 and 2005. All had been repatriated back to Nepal and had received rehabilitative services from Maiti Nepal, a non-governmental organization that works to assist trafficking victims. The word Maiti means mothers home in Nepali.

The researchers found that among the 287 girls and women, 38 percent tested positive for HIV. Among those with complete documentation of trafficking experiences (225 girls and women), the median age at time of trafficking was 17 years, with 33 girls (14.7 percent) trafficked prior to age 15 years. Compared to those trafficked at 18 years or older, girls trafficked prior to age 15 years had an increased risk for HIV, with 60.6 percent infected among this youngest age group. Risk was also associated with being trafficked specifically to Mumbai, India, and with longer durations in brothels.

HIV infection has been seen as perhaps the most critical health consequence of sex trafficking, but sex-trafficked girls and women are rarely studied leaving the prevalence of HIV and other health issues among this highly vulnerable population little understood, said Silverman. This study sheds new light on infection rates among a sex-trafficked population and exposes both the tragic existence of the youngest victims and the dire health consequences of this crime.

Silverman and his team suggest several likely explanations for the observed high risk for HIV infection among the youngest trafficked girls. Previous research on male brothel clients in India suggests that these men prefer very young girls, often presented as virgins, due to fear of HIV and other infection, as well as to the widespread myth that sex with a virgin will cure such illnesses. As a result of client demand and of the relatively high profits earned from prostituting these very young girls, brothel owners take steps to keep them in captivity for longer periods of time. The HSPH team found
'"/>

Contact: Christina Roache
croache@hsph.harvard.edu
617-432-6052
Harvard School of Public Health
31-Jul-2007


Page: 1 2 3

Related biology news :

1. New study demonstrates important role of glia in circadian timing
2. Success rates for prostate cancer depend on experience of surgeon
3. Pre-implantation genetic screening reduces both ongoing pregnancy and live birth rates in over 35s
4. Personalized approach to ovarian stimulation achieves high ART pregnancy rates
5. Sentinel lymph node biopsy is associated with breast cancer rates
6. Scripps research scientists show protein accelerates breast cancer progression in animal models
7. Stowers Institutes Workman Lab demonstrates mechanism for decoding histone modification marks
8. Bat flight generates complex aerodynamic tracks
9. Premature births may be linked to seasonal levels of pesticides and nitrates in surface water
10. BEMA Fentanyl demonstrates substantial transmucosal delivery
11. New treatments have major impact on heart failure rates

Post Your Comments:
(Date:4/14/2015)... 14, 2015 NXT-ID, Inc. (NASDAQ: NXTD ... focused on the growing mobile commerce market, announces that ... 2015 New York Design Awards under the category  ,Product ... City Design Awards are part of a global multi-disciplinary ... ratings from the marketplace, industry and judging panel. Winners ...
(Date:4/10/2015)... , April 10, 2015 ... addition of the "Security Competitive Profiles - NEC" ... http://photos.prnewswire.com/prnh/20130307/600769) , NEC will continue to supply ... to the market, with a company focus on the ... anticipated. Winning opportunities in the ...
(Date:4/6/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ... focused on the growing mobile commerce market, announced ... for MINIATURE, MULTI-PURPOSE ANTENNA METHOD AND SYSTEM ... NXT-ID introduces a new revolutionary method and system ... use of miniature antenna modules for multiple purposes ...
Breaking Biology News(10 mins):NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 2NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 3NEC Security Competitive Profile 2015 2NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 2NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 3NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 4
(Date:4/21/2015)... April 21, 2015 The North ... in 2014 to $605.1 million by 2019, at a ... Browse through the TOC of North ... of the industry trends and segments, with help of ... Early buyers will receive 10% customization ...
(Date:4/21/2015)... , April 21, 2015 Merrimack Pharmaceuticals, ... from a multi-arm Phase 1 study of MM-141, a ... presented in an oral session by Dr. Mansoor ... Cancer Research Annual Meeting in Philadelphia, PA. ... of MM-141 as a monotherapy and in combination with ...
(Date:4/21/2015)... PROVO, Utah , April 21, 2015  Tute Genomics, ... the hiring of Josh Forsythe as VP of ... that has witnessed a significant expansion in its commercial operations ... " Josh Forsythe is a ... Robison , MD MBA, CEO of Tute Genomics. "Josh,s vast ...
(Date:4/21/2015)... York (PRWEB) April 21, 2015 Progyny, ... Fertility Authority, LLC, announced that it has secured additional ... (KPCB), TPG Biotech, SR One and Merck Serono Ventures. ... to provide patients the best fertility outcomes by aligning ... the largest online marketplace for families seeking fertility solutions ...
Breaking Biology Technology:North America Biostimulants Market is Expected to Reach $605.1 Million by 2019, at a CAGR of 14.1% From 2014 to 2019 2North America Biostimulants Market is Expected to Reach $605.1 Million by 2019, at a CAGR of 14.1% From 2014 to 2019 3First-in-Human Phase 1 Trial of MM-141 Demonstrates Activity in Biomarker Positive Patients 2First-in-Human Phase 1 Trial of MM-141 Demonstrates Activity in Biomarker Positive Patients 3First-in-Human Phase 1 Trial of MM-141 Demonstrates Activity in Biomarker Positive Patients 4First-in-Human Phase 1 Trial of MM-141 Demonstrates Activity in Biomarker Positive Patients 5Tute Genomics Continues Expansion of Genomic Medicine Commercial Operations; Appoints Josh Forsythe as New VP of Marketing 2Tute Genomics Continues Expansion of Genomic Medicine Commercial Operations; Appoints Josh Forsythe as New VP of Marketing 3Tute Genomics Continues Expansion of Genomic Medicine Commercial Operations; Appoints Josh Forsythe as New VP of Marketing 4Announcing Progyny: Combining Best-in-Class Clinical Solutions with Consumer Expertise 2
Cached News: